BD, also known as Becton, Dickinson and Co., on Wednesday named Francesca DeMartino as senior vice president of investor relations for the company, effective Monday.
In this role, DeMartino will lead all aspects of communicating progress of the BD2025 strategy to investors and the financial community, including the Franklin Lakes-based company’s initiatives that drive shareholder value. She will report to Chris DelOrefice, executive vice president and chief financial officer for BD. She succeeds Kristen Stewart, who has been named senior vice president of enterprise strategy and insights for BD.
“Francesca is an accomplished leader with a long track record of success in investor relations, including extensive experience in the medical technology industry,” DelOrefice said. “She will lead BD’s efforts to highlight key milestones as we deliver on our strategy to drive growth through innovation.”
DeMartino has more than 20 years of combined experience in investor relations, communications and corporate finance, with her most recent position as vice president of investor relations at Medtronic.
Prior to joining Medtronic, DeMartino held positions of increasing responsibility at Johnson & Johnson, OMRIX Biopharmaceuticals, Macrocure Ltd., GCI Group and the Ruth Group. She began her career at Deutsche Bank AG as a financial analyst in the Health Care Investment Banking Group.
